Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-05

FDA Approved: PERSERIS — Supplemental Application (Indivior Inc.)

View source ↗

Summary

FDA approved a supplemental application for PERSERIS (risperidone) submitted by Indivior Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PERSERIS (RISPERIDONE)

Snippet

SUPPL AP for PERSERIS (RISPERIDONE)